3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
15
INDUSTRY
15
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Conditions
Recurrence
1
Colitis, Ulcerative
1
Interventions
Gemcitabine
15
Cisplatin
12
Radiotherapy
11
Metformin
8
Fluorouracil
8
Capecitabine
8
Paclitaxel
7
Oxaliplatin
7
Exercise
7
Indocyanine Green
6
Docetaxel
6
Cyclophosphamide
6
Control Groups
6
Surveys and Questionnaires
5
Standard of Care
5
Nivolumab
5
Letrozole
5
Irinotecan
5
pembrolizumab
4
durvalumab
4
Zoledronic Acid
4
Vinorelbine
4
Saline Solution
4
Preoperative Exercise
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Ifosfamide
4
Gefitinib
4
Drug Therapy
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
OTHER_GOV
×
Adalimumab
×
Clear all
NCT03011268
2025-05-31
BIOSTOP
Helse Møre og Romsdal HF
Phase NA
Completed
174 enrolled